Stamford Hospital Med. Oncology Hematology Res. is a clinical research site located in Stamford, Connecticut, United States 06902.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Stamford Hospital Med. Oncology Hematology Res. has participated in 1 clinical trials.
Therapeutic areas: Tumors With CDK4/6 Pathway Activation.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stamford Hospital Med. Oncology Hematology Res. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stamford Hospital Med. Oncology Hematology Res. has 1 clinical trials on record. Their work covers Tumors With CDK4/6 Pathway Activation.
Stamford Hospital Med. Oncology Hematology Res. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.